Clinical Trial Update: Clinical Intramuscular Gene Transfer Trial of rAAVrh74.MCK.Micro-Dystrophin to Patients With Duchenne Muscular Dystrophy [Phase 1]

View source ↗

Summary

Phase 1 intramuscular gene transfer trial using rAAVrh74.MCK.Micro-Dystrophin for Duchenne Muscular Dystrophy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• rAAVrh74.MCK.Micro-Dystrophin

Snippet

Sponsor: Jerry R. Mendell | Conditions: Duchenne Muscular Dystrophy | Phase 1 | Status: COMPLETED